View this email in your browser.
MAR
31
IN THIS ISSUE
  NEWS
  Informed Consent Exception will Prompt Experimental Trauma Treatment on 1,000 Patients
  NEWS
  Hopkins Begins Nation's First HIV-positive Organ Transplants
  PRODUCT
  Bioreactor Tubing Kits Speed Turnaround
  NEWS
  Common Fungicides May Play Role in Autism, Alzheimer's
  NEWS
  New Clues Identified in Childhood Cancer Syndrome

2016: Take Your Place Among 54 Years of R&D Excellence

2016 R&D 100 Awards

For more than a half century, R&D magazine has identified and honored the top 100 products introduced each year. With the considerable time and resources invested in your new product, make sure it is considered with the breakthrough technologies vying for the Award known as "the Oscars of Invention."

REGISTER NOW
 
FEATURED STORY

Biotech Startup Centrexion Therapeutics Adds to Its Pain Pipeline

Featured Story

Centrexion Therapeutics, a Baltimore-based biotech startup announced Wednesday that it will bolster its nonopioid pain pipeline with three new analgesic candidates from Boehringer Ingelheim.


Share Facebook Twitter Google+ LinkedIn StumbleUpon

FULL STORY
 
 

Integrated Biosafety Solutions for the Modern Laboratory

The Baker Company

What Makes Your Laboratory Unique? Your people, your protocols, the work you do to change the world - and the instruments and equipment that help you to reach your goals. You shouldn't have to fit your workflows around standard equipment. Your Equipment should be adaptable to you, while operating within the safety, performance, and compliance parameters that your work requires. In short, your laboratory equipment should work the way you do.


READ THE WHITEPAPER
 
 
NEWS

Informed Consent Exception will Prompt Experimental Trauma Treatment on 1,000 Patients

Thumbnail

Over the next three years, approximately 1,000 patients on the verge of death will automatically become part of a research program that has an exception from traditional informed-consent requirements. Although controversial, such experiments are exceedingly rare, and tightly regulated.


FULL STORY
 
 
NEWS

Hopkins Begins Nation's First HIV-positive Organ Transplants

Thumbnail

Surgeons in Baltimore for the first time have transplanted organs between an HIV-positive donor and HIV-positive recipients, a long-awaited new option for patients with the AIDS virus whose kidneys or livers also are failing.


FULL STORY
 
 

Innovative Method for Detecting and Quantifying Aflatoxins Using General Equipment

Horizon Technologies

With the requirement to increase testing of agricultural and food products for the presence of aflatoxins, reliable and convenient testing methods that utilize readily available standard laboratory tools are in demand. For the general laboratory, newer technologies for aflatoxin analysis may be financially unattainable. This app note focuses on the innovative method developed to accurately test aflatoxins using general equipment.


READ THE WHITEPAPER
 
 
FOCUS ON:

Bioreactor Tubing Kits Speed Turnaround

Thumbnail

Custom, Single-Use Bioreactor Tubing Kits, new from AdvantaPure, contain tubing, filters and connectors for harvest, vent, sparge and addition lines used in benchtop bioreactors.


FULL STORY
 
 
NEWS

Common Fungicides May Play Role in Autism, Alzheimer's

Thumbnail

Scientists have found a class of commonly used fungicides that produce gene expression changes similar to those in people with autism and neurodegenerative conditions, including Alzheimer's disease and Huntington's disease.


FULL STORY
 
 
NEWS

New Clues Identified in Childhood Cancer Syndrome

Thumbnail

New research may help doctors determine which issues are likely to manifest in children with the inherited cancer syndrome neurofibromatosis type 1 (NF1). The findings indicate that varying mutations in the NF1 gene may lead to different clinical outcomes.


FULL STORY
 
 
NEWS

CDC Expands Range of Zika Mosquito into Parts of Northeast

The mosquitoes that can transmit the Zika virus may live in a broader swath of the U.S. than previously thought - but that doesn't mean they'll cause disease here, federal health officials said Wednesday.


FULL STORY
 
Bioscience Technology
Facebook Twitter
Editor's Note: Beginning the week of April 4, Bioscience Technology will move from a daily e-newsletter format to a weekly e-newsletter, offering new research and insights every Monday. For life sciences news, research and applications, and industry insights continue to visit our website daily at www.biosciencetechnology.com.
SUBSCRIBEUNSUBSCRIBEABOUT USADVERTISE
This email was sent by: Bioscience Technology
100 Enterprise Drive - Suite 600 - Rockaway, NJ 07866-2129
We respect your right to privacy - click here to view our policy.

©2016 Bioscience Technology. All rights reserved.